2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
19
Spondylitis, Ankylosing
6
Psoriasis
4
Colitis, Ulcerative
4
Crohn Disease
3
Inflammatory Bowel Diseases
2
Uveal Melanoma
1
Thyroid Carcinoma, Anaplastic
1
Spondylarthritis
1
Sarcoidosis
1
Recurrence
1
Plaque Psoriasis
1
Osteoarthritis
1
Nephrotic Syndrome
1
Nephrosis, Lipoid
1
Mucopolysaccharidosis VI
1
Mucopolysaccharidosis II
1
Mucopolysaccharidosis I
1
Mucopolysaccharidoses
1
Melanoma
1
Macular dystrophy, corneal type 1
1
Kidney Diseases
1
Joint Diseases
1
Inflammation
1
Infections
1
Hidradenitis Suppurativa
1
Healthy Adult Male
1
Healthy
1
Glomerulosclerosis, Focal Segmental
1
Dupuytren Contracture
1
Interventions
rofecoxib
1
acetaminophen, codeine drug combination
1
World Health Organization oral rehydration solution
1
Vitamin D
1
Syringes
1
Oxycodone
1
Nutrition Assessment
1
Naloxone
1
Inosine Monophosphate
1
Injections, Intra-Articular
1
Fish Oils
1
Fatty Acids, Omega-3
1
Eicosapentaenoic Acid
1
Duration of Therapy
1
Docosahexaenoic Acids
1
Cholecalciferol
1
Arthroplasty, Replacement, Shoulder
1
Arthroplasty, Replacement, Elbow
1
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Osteoarthritis
×
Adalimumab
×
Clear all
NCT00597623
2012-07-26
DORA
Assistance Publique - Hôpitaux de Paris
Phase 3
Completed
84 enrolled